DECONSOLIDATIONS	12 Months Ended
Dec. 31, 2025
Restructuring and Related Activities [Abstract]
DECONSOLIDATIONS	DECONSOLIDATIONS On September 1, 2025, the Company made the decision to close our facility in the United Kingdom because of its financial performance, which was deemed a triggering event for long-lived asset impairment testing. As a result of the closure, a loss of $2.4 million was recognized related to impairment of the property, plant, and equipment at this location. Additionally, the Company ceased use of our leased facility on November 15, 2025, and adjusted the remaining right-of-use asset resulting in accelerated amortization of approximately $3.3 million of rent expense from accelerated amortization during the year ended December 31, 2025. During the fourth quarter of 2025, the Company completed the dissolution of operations at the London facility in the United Kingdom. All remaining net assets were turned over to a liquidator in accordance with the applicable laws and regulations in the United Kingdom and the Company will have no further continuing involvement. Deconsolidation of the entity was recognized due to loss of control which resulted in a gain of $3.2 million related to net liabilities absolved and reclassification of the currency translation adjustment from other comprehensive income. These transactions are included in cost related to closing location, net. The transactions consist of $2.4 million loss on London PPE, $3.3 million rent expense from accelerated amortization, offset by a $3.2 million gain on the deconsolidation as of December 31, 2025 related to net liabilities and $0.3 million income from reclassification of CTA.

DECONSOLIDATIONS

12 Months Ended

Dec. 31, 2025

Restructuring and Related Activities [Abstract]

On September 1, 2025, the Company made the decision to close our facility in the United Kingdom because of its financial performance, which was deemed a triggering event for long-lived asset impairment testing. As a result of the closure, a loss of $2.4 million was recognized related to impairment of the property, plant, and equipment at this location. Additionally, the Company ceased use of our leased facility on November 15, 2025, and adjusted the remaining right-of-use asset

resulting in accelerated amortization of approximately $3.3 million of rent expense from accelerated amortization during the year ended December 31, 2025.

During the fourth quarter of 2025, the Company completed the dissolution of operations at the London facility in the United Kingdom. All remaining net assets were turned over to a liquidator in accordance with the applicable laws and regulations in the United Kingdom and the Company will have no further continuing involvement. Deconsolidation of the entity was recognized due to loss of control which resulted in a gain of $3.2 million related to net liabilities absolved and reclassification of the currency translation adjustment from other comprehensive income.

These transactions are included in cost related to closing location, net. The transactions consist of $2.4 million loss on London PPE, $3.3 million rent expense from accelerated amortization, offset by a $3.2 million gain on the deconsolidation as of December 31, 2025 related to net liabilities and $0.3 million income from reclassification of CTA.